Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672381 · ClinicalTrials.gov registry record
NIRST and ICG-based Perfusion Imaging in Acute Compartment Syndrome
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 15
- Enrollment target
NCT05672381: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05672381 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05672381 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This is a prospective observational study of patients with suspected Acute Compartment Syndrome. The primary objective of this work is to determine whether intensity changes associated with the NIRST signal, reflecting oxy- and deoxy-hemaglobin and water concentrations or ICG fluorescence signal, reflecting tissue perfusion, can be associated with development of Acute Compartment Syndrome and identification of at-risk soft tissue and muscle.
Primary Outcome
The primary objective of this work is to determine whether total hemoglobin, oxygen saturation and water content imaged by NIRST or ICG fluorescence signal, reflecting tissue perfusion, can be associated with development of Acute Compartment Syndrome and identification of at-risk soft tissue and muscle.
Interventions
- PROCEDURE Lower extremity and/or upper extremity surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-05-12 |
| Est. Completion | 2025-09-16 |
What the finished NCT05672381 record still lists
NCT05672381 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lower extremity and/or upper extremity surgery is the first listed.
NCT05672381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05672381 about?
NCT05672381 is a clinical study titled "NIRST and ICG-based Perfusion Imaging in Acute Compartment Syndrome". This is a prospective observational study of patients with suspected Acute Compartment Syndrome. The primary objective of this work is to determine whether intensity changes associated with the NIRST signal, reflecting oxy- and deoxy-hemaglobin and water concentrations or ICG fluorescence signal, re...
What is the current status of trial NCT05672381?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2023-05-12. Estimated completion is 2025-09-16.
What interventions are being tested in trial NCT05672381?
The interventions under investigation include: Lower extremity and/or upper extremity surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05672381?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI